AbaÑo, Baby Girl 1 .
HRN: 24-60-64 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/27/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/27/2024
03/05/2024
IV
20mg
Q36
PSNB
Waiting Final Action
Indication: Prophylaxis Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes